(Q43755703)

26 November 2017

title

Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B. (English)

1 reference

26 November 2017

1 reference

M Shindo

1

1 reference

26 November 2017

T Okuno

2

1 reference

26 November 2017

M Matsumoto

3

1 reference

26 November 2017

M Takeda

4

1 reference

26 November 2017

T Takino

5

1 reference

26 November 2017

J Sokawa

6

1 reference

26 November 2017

A Iwata

7

1 reference

26 November 2017

Y Sokawa

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 March 1988

1 reference

26 November 2017

1 reference

26 November 2017

volume

8

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

366-370

1 reference

Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Interferon-induced enzymatic activities and their role in the antiviral state

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Monitoring of Interferon Therapy by Assay of (2′-5′) Oligo-Isoadenylate Synthetase in Human Peripheral White Blood Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

A sensitive immunoenzymometric assay for 2′,5′-oligoadenylate. Detection of elevated 2′,5′-oligoadenylate synthetase in human peripheral mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Sensitive radioimmuno assay for 2',5'-oligoadenylates using a novel 125I-labeled derivative of 2',5'-triadenylate 5'-triphosphate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

A classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840080229

7 January 2021

Identifiers

DOI

10.1002/HEP.1840080229

1 reference

26 November 2017

1 reference